Groups
|
Genotypes
|
Percentage of survival (Number of mice Survival/Total)a
|
---|
rSC0018(pS-SaoA)
|
ΔasdA33
|
0% (0/10)
|
rSC0018(pYA3493)
|
ΔasdA33
|
0% (0/10)
|
rSC0016(pS-SaoA)
|
ΔPcrp527::TT araC PBAD
crp Δpmi-2426 ΔrelA199::araC PBAD
lacI TT ΔsopB1686 ΔasdA33
|
100%** (10/10)
|
rSC0016(pYA3493)
|
ΔPcrp527::TT araC PBAD
crp Δpmi-2426 ΔrelA199::araC PBAD
lacI TT ΔsopB1686 ΔasdA33
|
0% (0/10)
|
rSC0011(pS-SaoA)
|
ΔPcrp527::TT araC PBAD
crp Δpmi-2426 ΔrelA199::araC PBAD
lacI TT ΔasdA33
|
40% (4/10)
|
rSC0011(pYA3493)
|
ΔPcrp527::TT araC PBAD
crp Δpmi-2426 ΔrelA199::araC PBAD
lacI TT ΔasdA33
|
0% (0/10)
|
BSG
|
NA
|
0% (0/10)
|
- ** P < 0.01 for the survival of mice immunized with rSC0016(pS-SaoA) compared with survival of mice immunized with rSC0011(pS-SaoA) or BSG.
-
aMice were challenged by i.p. with 25 × LD50 of SS2 at 7 weeks after immunization; This experiment was performed twice with same results. The data showed the result of the single experiment.